Giuseppe Patti Selected Research

Insulin (Novolin)

11/2023	Heterogeneity of outcomes within diabetic patients with atrial fibrillation on edoxaban: a sub-analysis from the ETNA-AF Europe registry.
1/2022	Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial.
1/2021	Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome.
1/2020	Endothelial Dysfunction, Fibrinolytic Activity, and Coagulation Activity in Patients With Atrial Fibrillation According to Type II Diabetes Mellitus Status.
1/2017	Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giuseppe Patti Research Topics

Disease

53	Hemorrhage 11/2023 - 07/2009
47	Atrial Fibrillation 04/2024 - 10/2006
47	Myocardial Infarction 08/2023 - 01/2004
44	Acute Coronary Syndrome 12/2023 - 10/2002
37	Thrombosis (Thrombus) 03/2024 - 05/2007
27	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 02/2002
26	Stroke (Strokes) 11/2023 - 07/2009
16	Stable Angina 07/2013 - 02/2002
13	COVID-19 03/2023 - 07/2020
11	Heart Failure 02/2024 - 12/2015
11	Diabetes Mellitus 01/2022 - 11/2008
10	Inflammation (Inflammations) 12/2022 - 03/2006
9	ST Elevation Myocardial Infarction 08/2023 - 09/2008
8	Coronary Artery Disease (Coronary Atherosclerosis) 08/2012 - 02/2002
7	Infarction (Infarctions) 11/2018 - 01/2004
6	Venous Thromboembolism 10/2021 - 01/2017
6	Transient Ischemic Attack 10/2021 - 04/2013
5	Thromboembolism 06/2023 - 07/2009
5	Ischemia 05/2023 - 07/2002
4	Embolism (Embolus) 11/2023 - 01/2017
4	Infections 01/2023 - 12/2020
4	Chronic Renal Insufficiency 10/2021 - 04/2014
4	Hypertension (High Blood Pressure) 01/2021 - 11/2014
4	Necrosis 06/2006 - 01/2004
4	Unstable Angina 02/2005 - 02/2002
3	Neoplasms (Cancer) 11/2023 - 07/2014
3	Ischemic Stroke 11/2023 - 03/2015
3	Peripheral Arterial Disease 05/2023 - 01/2017
3	Atherosclerosis 01/2023 - 06/2021
3	Pneumonia (Pneumonitis) 07/2022 - 12/2020
3	Connective Tissue Diseases (Connective Tissue Disease) 03/2022 - 04/2021
3	Heart Diseases (Heart Disease) 10/2021 - 01/2018
3	Coronary Disease (Coronary Heart Disease) 12/2019 - 10/2002
2	Hyperemia 05/2023 - 12/2005
2	Cardiogenic Shock 05/2023 - 04/2022
2	Death (Near-Death Experience) 01/2023 - 08/2012
2	Kidney Diseases (Kidney Disease) 12/2022 - 01/2021
2	Pulmonary Hypertension 03/2022 - 04/2021
2	Hematoma 02/2022 - 08/2012
2	Renal Insufficiency (Renal Failure) 06/2021 - 01/2017
2	Embolic Stroke 06/2021 - 01/2018
2	Pulmonary Arterial Hypertension 04/2021 - 04/2021
2	Vascular Diseases (Vascular Disease) 07/2020 - 11/2018
2	Patent Foramen Ovale 09/2018 - 03/2015
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018 - 07/2002
2	Anemia 01/2017 - 05/2015

Drug/Important Bio-Agent (IBA)

39	AnticoagulantsIBA 03/2024 - 07/2009
26	Clopidogrel (Plavix)FDA Link 11/2023 - 04/2005
19	omega-Chloroacetophenone (Mace)IBA 08/2023 - 02/2002
18	Vitamin K FDA Link 03/2024 - 01/2017
18	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2023 - 08/2004
16	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 02/2023 - 06/2016
16	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023 - 07/2009
13	TicagrelorIBA 11/2023 - 06/2013
12	Atorvastatin (Lipitor)FDA Link 01/2012 - 09/2005
10	Prasugrel Hydrochloride FDA Link 11/2022 - 06/2013
8	C-Reactive ProteinIBA 01/2021 - 02/2002
7	Warfarin (Coumadin)FDA LinkGeneric 11/2023 - 01/2017
6	edoxabanIBA 11/2023 - 01/2017
6	LipidsIBA 05/2023 - 03/2010
6	N(4)-oleylcytosine arabinosideIBA 02/2022 - 03/2017
6	MetalsIBA 11/2018 - 09/2008
5	Insulin (Novolin)FDA Link 11/2023 - 01/2017
5	MB Form Creatine KinaseIBA 10/2011 - 08/2004
5	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 04/2005 - 02/2002
4	oxidized low density lipoproteinIBA 12/2023 - 09/2010
4	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 04/2005 - 02/2002
3	Dabigatran FDA Link 04/2024 - 01/2021
3	LDL CholesterolIBA 12/2023 - 10/2018
3	InterleukinsIBA 12/2022 - 11/2008
3	Biomarkers (Surrogate Marker)IBA 03/2022 - 04/2021
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 02/2022 - 05/2015
3	RivaroxabanIBA 12/2021 - 07/2020
3	Fibrinolytic Agents (Antithrombotic Agents)IBA 07/2020 - 10/2018
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2023 - 01/2022
2	LigandsIBA 03/2022 - 12/2006
2	CytokinesIBA 01/2022 - 03/2006
2	apixabanIBA 01/2022 - 12/2021
2	Thrombin FDA Link 10/2021 - 08/2012
2	beta-cyclodextrin tetradecasulfate (CTDS)IBA 04/2021 - 04/2021
2	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 08/2012
2	CreatinineIBA 01/2021 - 02/2008
2	IceIBA 01/2019 - 11/2018
2	Ezetimibe (Zetia)FDA Link 10/2018 - 10/2015
2	erucylphosphocholineIBA 01/2018 - 04/2008
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 06/2016 - 01/2014
2	Eplerenone (Inspra)FDA LinkGeneric 12/2015 - 11/2014

Therapy/Procedure

78	Therapeutics 02/2024 - 04/2005
47	Percutaneous Coronary Intervention 12/2023 - 02/2002
25	Stents 01/2023 - 07/2002
8	Drug-Eluting Stents 10/2021 - 05/2007
5	Transcatheter Aortic Valve Replacement 04/2024 - 01/2019
5	Secondary Prevention 01/2021 - 03/2010
3	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2023 - 11/2021
3	Length of Stay 10/2021 - 10/2006
3	Artificial Respiration (Mechanical Ventilation) 10/2021 - 12/2020
2	Contraindications 03/2024 - 01/2019
2	Cardiac Resynchronization Therapy 02/2024 - 11/2022
2	Duration of Therapy 07/2022 - 10/2021
2	Drug Tapering 06/2021 - 01/2021